komta/iStock via Getty Images
- Enhabit (NYSE:EHAB) rose 3.7% after a report that activist AREX Capital Management is expected to win one board seat in a proxy fight, according to a Reuters report on Thursday.
- New York-based AREX Capital has been pushing for seven board seats at the home health and hospice provider, in which it has about 5% stake. The fund also wants Enhabit to sell itself. The annual meeting is Thursday.
- Earlier this month, proxy advisory firm ISS recommended shareholders of Enhabit (EHAB) vote for three of Arex’ board nominees at the upcoming annual meeting.
